ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells

Takahashi, H., Hosono, K., Uchiyama, T., Sugiyama, M., Sakai, E., Endo, H., Maeda, S., Schaefer, K. L., Nakagama, H., & Nakajima, A. (2010). PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study. PPAR Research, 2010(), 153-156. https://doi.org/10.1155/2010/257835
翁瑋廷（2011）。Study on the tumor suppressor function of PCDH10 in colorectal cancer〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.00237
黃國軒（2011）。Overexpression of aldo-keto reductase 1C2 is associated with disease progression in patients with prostatic cancer〔博士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2011.00048
Bao, J., Ni, Y., Qin, H., Xu, L., Ge, Z., Zhan, F., Zhu, H., Zhao, J., Zhou, X., Tang, X., & Tang, L. (2014). Rab27b Is a Potential Predictor for Metastasis and Prognosis in Colorectal Cancer. Gastroenterology Research and Practice, 2014(), 965-971-132. https://doi.org/10.1155/2014/913106
Wang, D., & DuBois, R. N. (2008). Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer. PPAR Research, 2008(), 253-259-124. https://doi.org/10.1155/2008/931074